|
|||
|
|||
 |
|||
|
6/26/2010 - One of Nation's Leading Chemists to deliver Commencement address
An outstanding chemist and alumna will be commencement speaker at Judson College on June 26.
Dr. Ellis-Grosse began her career in 1995 as a clinical pharmacokineticist with Wyeth Pharmaceuticals in Radner, Pa. Within two years she became the senior clinical pharmacokineticist and later was named assistant director of the corporation's clinical pharmacology/pharmacokinetics division. At Wyeth she was involved in research projects related to infectious diseases and to cardiovascular, women's health, transplant, oncology and hematology topics. In 2001 she became director of Wyeth's cardiovascular and infectious disease department, clinical research and development in Collegeville, Pa. She later became senior director and then a corporate vice-president. Among her many accomplishments in Collegeville were the building of the company's global infectious diseases division and management of 50 staff members in two sites; expanded regional research sites into Asia and Latin America; initiation of regulatory and clinical strategy in Africa, including Moxidectin for the treatment of onchocerciasis in collaboration with the World Health Organization and the European Medicines Agency and service as the project leader for rapid start-up of Wyeth's corporate hemophilia program that achieved project goals ahead of schedule. She and her husband, Geoff, and son, Will, moved to Marietta, Ga. in 2006 to be closer to her parents who were in declining health. In Marietta, she established e2gBiopharmaceutical Consulting that provides global drug development counsel. Dr. Ellis-Grosse was honored by the American Chemical Society with the "Heroes of Chemistry Award" in 2006, recognizing her work in the development of Tygasil, an antimicrobial drug that has been shown to be highly valuable in the treatment of pneumonia, intra-abdominal infections, skin and skin structure infections. Dr. Ellis-Grosse is a member of the Infectious Disease Society of America, the American Society for Microbiology and the European Society for Clinical Microbiology and Infectious Disease. She and a fellow researcher obtained two U.S. patents as inventors of Vasopressin Antagonist and Diuretic Combination in 2002 and 2003. Commencement will be at 11 a.m. in the Alumnae Auditorium. *Article courtesy of the Judson College Public Relations Department.
|
 |
Dr. Evelyn J. Ellis-Grosse, a native of Centre, Ala., enrolled at Judson College in 1984. She studied
 |
|
 |
 |
||